AI assistant
DYNAVAX TECHNOLOGIES CORP — Director's Dealing 2020
Feb 20, 2020
32130_dirs_2020-02-20_8baff3b8-078e-42fd-b7c1-eb5e888bd47d.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: DYNAVAX TECHNOLOGIES CORP (DVAX)
CIK: 0001029142
Period of Report: 2020-02-18
Reporting Person: Novack David F (President & COO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-02-18 | Common Stock | F | 23085 | $5.03 | Disposed | 123899 | Direct |
Footnotes
F1: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.
F2: The reporting person is reporting the sale of 23,085 shares of common stock to satisfy the reporting person's tax withholding obligations in connection with the delivery of common stock to the reporting person on February 18, 2020.
F3: This transaction was executed in multiple trades at prices ranging from $4.97 to $5.14; the price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide full information regarding the number of shares and prices at which the transactions were effected upon request to the SEC staff, Dynavax, or a security holder of Dynavax.
F4: Includes 2,500 shares acquired under Issuer's 2014 Employee Stock Purchase Plan (ESPP) on February 14, 2020.